Massive 5,000-Patient study tracks kidney drug safety in real world
NCT ID NCT07124039
Summary
This study is observing how a kidney-protecting drug called finerenone is used and how safe it is for patients with chronic kidney disease and type 2 diabetes in real-world Chinese hospitals. It will track 5,000 patients' health records to see how their kidney function and potassium levels change after starting the drug. The goal is to understand the drug's real-world safety and effectiveness outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inspur Tianjin Regional Electronic Health Records Database
Tianjin, Tianjin Municipality, 301799, China
Conditions
Explore the condition pages connected to this study.